These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 27823920)
21. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. Han K; Kim JH World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959 [TBL] [Abstract][Full Text] [Related]
23. Inherited hepatocellular carcinoma. Villanueva A; Newell P; Hoshida Y Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):725-34. PubMed ID: 20955973 [TBL] [Abstract][Full Text] [Related]
24. [Drug research and development and unmet needs for advanced-stage hepatocellular carcinoma]. Zhou HB; Hu HP Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):306-311. PubMed ID: 38733184 [TBL] [Abstract][Full Text] [Related]
25. Recent advances in the management of hepatocellular carcinoma. Zhang S; Yue M; Shu R; Cheng H; Hu P J BUON; 2016; 21(2):307-11. PubMed ID: 27273938 [TBL] [Abstract][Full Text] [Related]
26. Management of hepatocellular carcinoma. Del Pozo AC; López P Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209 [TBL] [Abstract][Full Text] [Related]
27. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. Carloni V; Luong TV; Rombouts K Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349 [TBL] [Abstract][Full Text] [Related]
28. Treatment of hepatocellular carcinoma. Blum HE Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809 [TBL] [Abstract][Full Text] [Related]
29. Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma. Peng ZW; Chen MS Oncology; 2013; 84 Suppl 1():40-3. PubMed ID: 23428857 [TBL] [Abstract][Full Text] [Related]
30. [Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy]. Parisod L; Duran R; Denys A; Digklia A Rev Med Suisse; 2017 May; 13(563):1032-1034. PubMed ID: 28636293 [TBL] [Abstract][Full Text] [Related]
31. [Hepatocellular carcinoma]. Semela D; Heim M Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143 [TBL] [Abstract][Full Text] [Related]
32. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction. Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547 [TBL] [Abstract][Full Text] [Related]
33. Surgical resection and liver transplantation for hepatocellular carcinoma. Akoad ME; Pomfret EA Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669 [TBL] [Abstract][Full Text] [Related]
34. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma]. Zhang DZ; Niu JQ Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237 [TBL] [Abstract][Full Text] [Related]
35. Treatment of hepatocellular carcinoma. Forner A; Hessheimer AJ; Isabel Real M; Bruix J Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993 [TBL] [Abstract][Full Text] [Related]
36. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309 [TBL] [Abstract][Full Text] [Related]